Gerry Castillo
Chief Tech/Sci/R&D Officer at PharmaIN Corp.
Gerry Castillo active positions
| Companies | Position | Start | End |
|---|---|---|---|
PharmaIN Corp.
 PharmaIN Corp. Pharmaceuticals: MajorHealth Technology PharmaIN Corp. develops affinity-based drug delivery solutions for biotech and pharmaceutical applications. It develops drug therapies using its proprietary, novel drug delivery platform called Protected Graft Co-polymer. The company was founded by Elijah M. Bolotin in 2000 and is headquartered in Bothell, WA. | Chief Tech/Sci/R&D Officer | - | - |
Career history of Gerry Castillo
Former positions of Gerry Castillo
| Companies | Position | Start | End |
|---|---|---|---|
ProteoTech, Inc.
 ProteoTech, Inc. Medical/Nursing ServicesHealth Services ProteoTech, Inc. operates as a private drug development company. It focuses on targeting amyloid diseases. The firm is utilizing its amyloid and proteoglycan expertise in an effort to transform the lives of victims of Alzheimer's disease, Parkinson's disease, type 2 diabetes, and systemic amyloidosis. The company was founded in 1996 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
Training of Gerry Castillo
| University of Saskatchewan | Undergraduate Degree |
| University of Windsor | Graduate Degree |
| University of Toronto | Doctorate Degree |
Statistics
International
| Canada | 4 |
| United States | 3 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 2 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
PharmaIN Corp.
PharmaIN Corp. Pharmaceuticals: MajorHealth Technology PharmaIN Corp. develops affinity-based drug delivery solutions for biotech and pharmaceutical applications. It develops drug therapies using its proprietary, novel drug delivery platform called Protected Graft Co-polymer. The company was founded by Elijah M. Bolotin in 2000 and is headquartered in Bothell, WA. | Health Technology |
ProteoTech, Inc.
ProteoTech, Inc. Medical/Nursing ServicesHealth Services ProteoTech, Inc. operates as a private drug development company. It focuses on targeting amyloid diseases. The firm is utilizing its amyloid and proteoglycan expertise in an effort to transform the lives of victims of Alzheimer's disease, Parkinson's disease, type 2 diabetes, and systemic amyloidosis. The company was founded in 1996 and is headquartered in Seattle, WA. | Health Services |
- Stock Market
- Insiders
- Gerry Castillo
- Experience
